CMXHF News and Press, CSL Ltd.

2026-07-08 11:57:02 ET More on Sanofi, Sanofi, etc. Sanofi 'Strong Buy': Continued Dupxient Sales Growth And Sarclisa OBI First CSL Limited (CSLLY) Shareholder/Analyst Call Transcript CSL Limited (CSLLY) Shareholder/Analyst Call - Slideshow Sanofi's Nexviazym...

2026-07-06 09:55:28 ET Many retail investors are still skeptical about Big Pharma players.... Read the full article on Seeking Alpha For further details see: My Top 5 Pharma Stocks Wall Street Ignores

2026-06-26 10:29:29 ET More on Eli Lilly, Incyte, etc. Eli Lilly: Pharma With Unstoppable Momentum Targets Pain With Latest M&A Deal Eli Lilly: The Macro Health Crisis Is Still Undervalued Incyte: I Am Moving From Hold To Buy Medicare GLP-1 Bridge: What t...

2026-06-23 08:21:24 ET Moderna, Inc. ( MRNA ), the biotech company best known for producing a hugely successful Covid vaccine, has seen its share price plummet almost 90% from its Covid-era peak. Its MRNA-based Covid vaccine sales have fallen as government orders have dwindled amids...

2026-05-16 08:23:53 ET More on Amgen, Kissei Pharmaceutical Co., Ltd., etc. CSL Limited (CSLLY) Shareholder/Analyst Call Transcript Amgen Inc. (AMGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript CSL Limited (CSLLY) Shareholder/Analyst Call...

2026-05-11 11:15:03 ET Citigroup analyst issues NEUTRAL recommendation for CMXHF on May 11, 2026 02:27PM ET. CMXHF was trading at $87 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations

2026-05-05 03:44:37 ET I don't think CSL ( CSLLY ) will return to a premium growth multiple right away. However, at least some of the biggest impediments are either self-inflicted operational issues, temporary policy disruptions, or lower-quality revenue streams being rationalized.....

2026-03-30 09:17:55 ET Since my article , "My Top 5 Biotech Stocks Big Pharma Could Buy Next," Kamada shares ( KMDA ) have risen 22.4%, outperforming the so-called "bellwether" for the biotech investors, the iShares Biotechnology ETF [6.5% return] ( IBB ), as well as the S&a...

2026-02-10 22:24:20 ET CSL Limited (CSLLY) Q2 2026 Earnings Call February 10, 2026 6:00 PM EST Company Participants Mark Dehring Gordon Naylor Ken Lim - Chief Financial Officer Andy Schmeltz - Chief Commercial Officer Dave Ross - Senior VP & GM of S...

2026-02-10 06:14:33 ET CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of Interim CEO February 10, 2026 1:00 AM EST... Read the full article on Seeking Alpha For further details see: CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of I...